BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24296945)

  • 1. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
    Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
    Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of nodal marginal zone lymphoma.
    Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D
    Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
    Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G
    J Exp Med; 2012 Aug; 209(9):1537-51. PubMed ID: 22891273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
    Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
    BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
    Parry M; Rose-Zerilli MJ; Gibson J; Ennis S; Walewska R; Forster J; Parker H; Davis Z; Gardiner A; Collins A; Oscier DG; Strefford JC
    PLoS One; 2013; 8(12):e83244. PubMed ID: 24349473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
    Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
    Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB deregulation in splenic marginal zone lymphoma.
    Spina V; Rossi D
    Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
    Spina V; Rossi D
    Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic marginal-zone lymphoma: ontogeny and genetics.
    Baliakas P; Strefford JC; Bikos V; Parry M; Stamatopoulos K; Oscier D
    Leuk Lymphoma; 2015 Feb; 56(2):301-10. PubMed ID: 24798744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
    Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
    Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
    van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
    Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
    Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing identifies recurrent
    Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
    Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue proteomics of splenic marginal zone lymphoma.
    Polati R; Brandi J; Dalai I; Zamò A; Cecconi D
    Electrophoresis; 2015 Jul; 36(14):1612-21. PubMed ID: 25873066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis.
    Ruiz-Ballesteros E; Mollejo M; Rodriguez A; Camacho FI; Algara P; Martinez N; Pollán M; Sanchez-Aguilera A; Menarguez J; Campo E; Martinez P; Mateo M; Piris MA
    Blood; 2005 Sep; 106(5):1831-8. PubMed ID: 15914563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
    Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
    Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.